WFC
58
8
CRM
65
6
PEP
33
4
EA
41
3
BIIB
36
8
JCI
44
7
ZION
49
9
T
32
2
KHC
11
2
BLK
47
3
AXP
63
3
FSLR
50
6
MAS
46
3
CNP
59
17
AMGN
42
14
DG
14
6
MDLZ
28
2
BMY
40
-5
MU
42
14
MSI
52
3
WFC
58
8
CRM
65
6
PEP
33
4
EA
41
3
BIIB
36
8
JCI
44
7
ZION
49
9
T
32
2
KHC
11
2
BLK
47
3
AXP
63
3
FSLR
50
6
MAS
46
3
CNP
59
17
AMGN
42
14
DG
14
6
MDLZ
28
2
BMY
40
-5
MU
42
14
MSI
52
3
Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
44

FOLD
Amicus Therapeutics

Last Price:
$9.81
Seasonality Move:
5.47%
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
$245.56
Seasonality Move:
2.78%
Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.80. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $245.50. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $245.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 45.87 Sell
Chaikin Money Flow: 1508811 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.59 - 9.99) Buy
Bollinger Bands (100): (9.99 - 11.55) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.01 Sell
Relative Strength Index (14 RSI): 43.61 Sell
Chaikin Money Flow: 935904 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (240.56 - 254.54) Sell
Bollinger Bands (100): (251.01 - 281.19) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.82 Sell
20-day SMA: 9.84 Sell
50-day SMA: 10.45 Sell
200-day SMA: 10.64 Sell
8-day EMA: 9.79 Buy
20-day EMA: 9.9 Sell
50-day EMA: 10.25 Sell
200-day EMA: 10.81 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 244.71 Buy
20-day SMA: 249.56 Sell
50-day SMA: 264.07 Sell
200-day SMA: 220.46 Buy
8-day EMA: 244.75 Buy
20-day EMA: 249.26 Sell
50-day EMA: 256.57 Sell
200-day EMA: 234.24 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):